Evidence map›Paper›PMID 35782798›Full record

ReviewIndian journal of surgical oncology2022

Patients' Survival with Astrocytoma After Treatment: a Systematic Review and Meta-analysis of Clinical Trial Studies.

Nader Salari, Reza Fatahian, Mohsen Kazeminia, Amin Hosseinian-Far, Shamarina Shohaimi, Masoud Mohammadi

Open access · greenAbstract readReview
In one paragraph

Review in Indian journal of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Inhibition of TRAF3IP2 Modulates NAMPT and NAD Metabolism in Glioblastoma.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  4. Rat Glioma 101.8 Tissue Strain: Molecular and Morphological Features.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Nader SalariDepartment of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Reza FatahianDepartment of Neurosurgery, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mohsen KazeminiaStudent Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Amin Hosseinian-FarDepartment of Business Systems & Operations, University of Northampton, Northampton, UK.
Shamarina ShohaimiDepartment of Biology, Faculty of Science, University Putra Malaysia, Serdang, Selangor Malaysia.
Masoud MohammadiCellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash , Iran.ORCID 0000-0002-5722-8300
Kermanshah University of Medical Sciences · IRGerash University of Medical Sciences · IRUniversiti Putra Malaysia · MYUniversity of Northampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About half of the brain tumours are primary and the rest are metastatic. The impact of each of these treatments alone or together on the prognosis of patients with astrocytoma tumours, especially low-grade astrocytoma, is unclear which may pose many challenges in the decision-making of surgeons and patients. Considering the importance of patient's outcomes with astrocytoma and lack of general statistics, this study aimed to determine the survival of patients with high-grade astrocytoma and low-grade astrocytoma after treatments. This study follows a systematic review and a meta-analysis approach. Following a systematic review and meta-analysis method, articles dated from 1982 to March 2020 were extracted from Embase, ScienceDirect, Scopus, PubMed and Web of Science (WoS) international databases. Random effects model was used for analysis, and heterogeneity of studies was investigated considering the

Indexed as

AstrocytomaHigh gradeLow gradeMeta-analysisPrimary brain tumours

Identifiers

PMID35782798
PMCPMC9240140
OpenAlexW4224882495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.